Boston Scientific's 2026 Guidance Cut Deepens as Recovery Timeline Slips to 2028

What happened

Boston Scientific has reduced its 2026 financial guidance again, signaling that headwinds in its Electrophysiology and WATCHMAN franchises are more persistent than management previously indicated. The company now expects a broader operational recovery to materialize only by 2028, as EP market share losses to competitors and a sustained slowdown in Watchman procedure volumes weigh on near-term growth. This guidance adjustment comes despite the Q1 2026 reset and reflects a deteriorating competitive landscape where newer pulsed field ablation systems from rivals are gaining traction. The delay in margin improvement further complicates the financial picture ahead of the $14.5 billion Penumbra acquisition, which requires significant debt financing. Investors now face an extended period of uncertainty, with the stock's valuation remaining under pressure until concrete signs of stabilization emerge.

Implication

The pushback of a meaningful recovery to 2028 materially erodes the near-term investment case, as the key drivers—EP share stabilization and WATCHMAN volume rebound—are now unlikely to materialize within the next 12 months. This increases the risk that the Penumbra acquisition becomes a leverage overhang before top-line growth recovers, potentially triggering covenant stress or rating downgrades. Until management can demonstrate halted share losses and procedure volume inflections, the stock is likely to trade closer to bear-case valuations, with any rallies selling into. The wait-and-see stance is reinforced, with Q3 2026 prints now critical for assessing whether the thesis is broken or merely delayed.

Thesis delta

The narrative shifts from a near-term stabilization bet to a longer-dated recovery story, as the guidance cut confirms that EP share losses and Watchman weakness are not transient. The investment thesis now requires a multi-year holding period with elevated balance-sheet risk, reducing conviction in a timely payoff.